Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
tirzepatide is $397 for the first month, then $497/month
This shorter activity window allows the peptide to interact with natural growth hormone pulse patterns without prolonged receptor stimulation
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist
coli , which can induce satiety signaling by enhancing the PYY production in intestinal mucosal cells [179]
Patient safety advice includes: Maintaining good injection technique and site rotation to minimise local reactions Staying up to date with routine vaccinations, including annual influenza and pneumococcal vaccines as recommended for people with diabetes Monitoring for signs of infection and seeking prompt medical advice if concerned Following 'sick day rules' during illness maintain hydration, continue medication if possible, but temporarily pause GLP-1 treatment if unable to keep fluids down Reporting suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app) Patients should not discontinue their GLP-1 receptor agonist due to concerns about immune function without first consulting their prescribing clinician
US$ 23.95
US$ 26.90
US$ 26.65
US$ 20.20
